Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s12890-016-0223-3
Published Online: 2016-04-30
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Donohue, James F.
Wise, Robert
Busse, William W.
Garfinkel, Sandra
Zubek, Valentina B.
Ghafouri, Mo
Manuel, Raymond C.
Schlenker-Herceg, Rozsa
Bleecker, Eugene R.
Funding for this research was provided by:
Boehringer Ingelheim Pharmaceuticals, Inc.